Cerus (CERS) Depreciation & Amortization (CF) (2010 - 2026)
Cerus (CERS) reported Depreciation & Amortization (CF) of $447000.0 for Q1 2026, up 45.6% on a YoY basis from $307000.0 in Q1 2025, and up 13.74% sequentially from $393000.0 in Q4 2025.
Cerus (CERS) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Cerus (CERS) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $447000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 45.6% year-over-year to $447000.0; the trailing twelve-month figure through Mar 2026 stood at $1.6 million (up 2.29% YoY), and the FY2025 full-year result was $1.4 million, down 23.13% from the prior year.
- Depreciation & Amortization (CF) rose to $447000.0 in Q1 2026, from $393000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $865000.0 in Q1 2022 to a low of $307000.0 in Q1 2025.
- A 5-year average of $547705.9 and a median of $631000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) tumbled 51.35% in 2025 and surged 45.6% in 2026, its largest moves.
- Tracing CERS's Depreciation & Amortization (CF) over 5 years: stood at $649000.0 in 2022, then slipped by 0.31% to $647000.0 in 2023, then sank by 48.69% to $332000.0 in 2024, then advanced by 18.37% to $393000.0 in 2025, then increased by 13.74% to $447000.0 in 2026.
- Business Quant data shows CERS's Depreciation & Amortization (CF) at $447000.0 in Q1 2026, $393000.0 in Q4 2025, and $382000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Cerus | 600.87 Mn | 520.44 Mn | 27.89 Mn | 447,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447,000.00 |
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | 393,000.00 |
| Dec 31, 2025 | 393,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 344,000.00 |
| Jun 30, 2025 | 344,000.00 |
| Mar 31, 2025 | 307,000.00 |
| Mar 31, 2025 | 307,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Sep 30, 2024 | 412,000.00 |
| Jun 30, 2024 | 480,000.00 |
| Jun 30, 2024 | 480,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 647,000.00 |
| Dec 31, 2023 | 647,000.00 |